The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II trial of Voyager-V1 (vesicular stomatitis virus expressing human IFNβ and NIS, VV1), in combination with cemiplimab (C) in patients with NSCLC, melanoma, HCC or endometrial carcinoma.
 
Mario Sznol
Stock and Other Ownership Interests - Actym Therapeutics; Adaptive Biotechnologies; Amphivena; EvolveImmune Therapeutics; Intensity Therapeutics; Nextcure; Torque
Consulting or Advisory Role - Abbvie; Adaptimmune; Agenus; Alligator Bioscience; Almac Diagnostics; Anaeropharma; Array BioPharma; AstraZeneca/MedImmune; BioNTech; Boehringer Ingelheim; Boston Pharmaceuticals; Bristol-Myers Squibb; Chugai/Roche; Dragonfly Therapeutics; Genentech/Roche; Genmab; Genocea Biosciences; GI Innovation; immunocore; Innate Pharma; Lilly; Modulate Pharma; Modulate Pharma; Molecular Partners; Nektar; Newlink Genetics; Numab; Pieris Pharmaceuticals; Pierre Fabre; Seagen; SERVIER; Symphogen; Torque; Verastem; Zelluna
Other Relationship - CEC Oncology; Dava Oncology; Haymarket Media; Physicans' Education Resource
 
Jose Lutzky
Consulting or Advisory Role - Array BioPharma; Bristol-Myers Squibb; Novartis
Speakers' Bureau - Array BioPharma; Novartis; Regeneron
Research Funding - Amgen (Inst); AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Elios Pharmaceutical (Inst); Genentech/Roche (Inst); Immunocore (Inst); Incyte (Inst); Iovance Biotherapeutics (Inst); Merck (Inst); Merck Serono (Inst); Novartis (Inst); Pfizer (Inst); Regeneron (Inst); Viralytics (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Novartis; Pfizer
 
Alex A. Adjei
Research Funding - Bayer Schering Pharma (Inst); I-Mab (Inst); Kura Oncology (Inst); MabSpace Biosciences (Inst); Tesaro (Inst)
(OPTIONAL) Uncompensated Relationships - Merck KGaA; Swiss Rockets; Zai Lab
 
Steven Francis Powell
Consulting or Advisory Role - Bristol-Myers Squibb (Inst)
Research Funding - Actuate Therapeutics (Inst); AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Incyte (Inst); Merck Sharp & Dohme (Inst); Novartis (Inst); Pfizer (Inst); Vyriad (Inst)
 
Aiwu Ruth He
Consulting or Advisory Role - Eisai; Genentech/Roche; Merck
Speakers' Bureau - Bristol-Myers Squibb; Eisai; Exelixis
Research Funding - Genentech; Merck
 
Manish Patel
Consulting or Advisory Role - Nektar
 
Steven O'Day
Honoraria - Agenus; Biothera; Bristol-Myers Squibb; ImaginAb; Merck; RadImmune
Consulting or Advisory Role - Agenus; Biothera; Bristol-Myers Squibb; ImaginAb; Merck; RadImmune
Speakers' Bureau - Bristol-Myers Squibb
Research Funding - Agenus (Inst); Amgen (Inst); Biothera (Inst); Bristol-Myers Squibb (Inst); Exicure (Inst); Genocea Biosciences (Inst); Incyte (Inst); Merck (Inst); Ultimovacs (Inst)
Travel, Accommodations, Expenses - Agenus; Bristol-Myers Squibb; Caris MPI; ImaginAb; Merck
 
Naimish B. Pandya
Employment - NexImmune; Northern Biologics
Consulting or Advisory Role - GlaxoSmithKline; Incyte; Tizona Therapeutics, Inc.; Vyriad
Travel, Accommodations, Expenses - NexImmune; Northern Biologics
 
Stephen Kaesshaefer
No Relationships to Disclose
 
Monica Reckner
Consulting or Advisory Role - Vyriad
 
Cheryl Brown
Consulting or Advisory Role - Vyriad
 
Rosa M Diaz
Employment - Vyriad
Travel, Accommodations, Expenses - Vyriad
 
Luke Russell
Employment - Vyriad
Stock and Other Ownership Interests - Vyriad
Patents, Royalties, Other Intellectual Property - Oncolytic Virus expressing PTEN-alpha
 
Kah Whye Peng
Stock and Other Ownership Interests - Vyriad
Patents, Royalties, Other Intellectual Property - Vyriad
Other Relationship - Vyriad
 
Erol Wiegert
Employment - MOLOGEN
Consulting or Advisory Role - Vyriad
 
Giuseppe Gullo
Employment - Regeneron
Stock and Other Ownership Interests - Regeneron
 
Frank A. Seebach
Employment - Regeneron
Leadership - Regeneron
Stock and Other Ownership Interests - Regeneron
 
Israel Lowy
Employment - Regeneron
Stock and Other Ownership Interests - Regeneron
Patents, Royalties, Other Intellectual Property - Regeneron
 
Alice Susannah Bexon
Employment - Bexon Clinical Consulting
Leadership - SapVax; Vyriad
Stock and Other Ownership Interests - Sapience Therapeutics; Vyriad
Travel, Accommodations, Expenses - Sapience Therapeutics; Vyriad